A bi-national perspective on the management of young patients with colorectal cancer

ANZ Journal of Surgery

Volumn 83, Issue 9, 2013, Pages 636-640

  Warrier, Satish K ^a   Lynch, A Craig ^a,b   Heriot, Alexander G ^a,b  

^a Epworth Healthcare ^*  (Australia)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Colorectal cancer; Colorectal surgery; HNPCC

Indexed keywords

ADULT; AGE; AGED; ANAMNESIS; ARTICLE; AUSTRALIA; CLINICAL COMPETENCE; CLINICAL PRACTICE; COLON POLYPOSIS; COLON RESECTION; COLONOSCOPY; COLORECTAL CANCER; COLORECTAL SURGERY; COLORECTAL TUMOR; DECISION SUPPORT SYSTEM; FEMALE; HEALTH CARE SURVEY; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; NEW ZEALAND; RISK ASSESSMENT; STATISTICS; UTILIZATION REVIEW;

COLORECTAL CANCER; COLORECTAL SURGERY; HNPCC;

ADENOMATOUS POLYPOSIS COLI; ADULT; AGE FACTORS; AGED; AUSTRALIA; CLINICAL COMPETENCE; COLECTOMY; COLONOSCOPY; COLORECTAL NEOPLASMS; COLORECTAL SURGERY; DECISION SUPPORT TECHNIQUES; FEMALE; HEALTH CARE SURVEYS; HUMANS; MALE; MEDICAL HISTORY TAKING; MIDDLE AGED; NEW ZEALAND; PHYSICIAN'S PRACTICE PATTERNS; RISK ASSESSMENT;

EID: 84883349662     PISSN: 14451433     EISSN: 14452197     Source Type: Journal    
DOI: 10.1111/ans.12071     Document Type: Article

References (34)

1. Source: Australian Institute of Health and Welfare (AIHW) and Australian Association of Cancer Registries (AACR). Cancer in Australia, an Overview, 2006. AIHW cat. no. CAN 32. Canberra: AIHW, 2007.
2. Southey MC, Jenkins MA, Mead L etal. Use of molecular tumour characteristics to prioritise mismatch repair gene testing in early-onset colorectal cancer. J. Clin. Oncol. 2005; 23: 6524-6532.
3. Farrington SM, Lin-Goerke J, Ling J etal. Systematic analysis of hMSH2 and hMLH1 in young colon cancer patients and controls. Am. J. Hum. Genet. 1998; 63: 749-759.
4. Shureqi I, Cooksley CD, Morris J etal. Effect of age on risk of a second primary colorectal cancer. J. Natl Cancer Inst. 2001; 93: 1264-1266.
5. Ringland CL, Arkenau HT, O Connell LO, Ward RL. Second Primary Colorectal cancers (SPCRCs) experiences from a large Australian Cancer Registry. Ann. Oncol. 2010; 21: 92-97.
6. NHMRC. Guidelines for the Prevention, Early Detection and Management of CRC. Canberra, ACT: Commonwealth of Australia, 2005.
7. Vaseb HF, de Vos tot Nederveen C. Cancer: Lynch syndrome - how should colorectal cancer be managed? Nat. Rev. Gastroenterol. Hepatol. 2011; 8: 184-186.
8. Available from URL: http://www.fionnotoole.com/CSSANZ_survey.
9. Smith K, Rodriguez-Bigas MA. Role of surgery in familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer (Lynch syndrome). Surg. Oncol. Clin. N. Am. 2009; 18: 705-715.
10. Ringland CL, Arkenau HT, Oconnell LO, Ward RL. Second primary colorectal cancers (SPCRCs) experiences from a large Australian Cancer Registry. Ann. Oncol. 2010; 21: 92-97.
11. Jass JR. Colorectal adenoma progression and genetic change: is there a link? Ann. Med. 1995; 27: 301-306.
12. Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC < Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999; 116: 1453-1456.
13. Jass J. Hereditary non-polyposis colorectal cancer: the rise and fall of a confusing term. World J. Gastroenterol. 2006; 12: 4943-4950.
14. Parry S, Win AK, Parry B etal. Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery. Gut 2010; 60: 950-957.
15. Kalady MF, McGannon E, Vogel JD, Manilich E, Fazio VW, Church JM. Risk of colorectal adenoma and carcinoma after colectomy for colorectal cancer in patients meeting Amsterdam criteria. Ann. Surg. 2010; 252: 507-513.
16. Elton C, Makin K, Cohen CRG. Outcome after ileorectal anastamosis. Br. J. Surg. 2003; 90: 59-65.
17. Church JM, Fazio VW, Lavery IC, Oakley JR, Milsom J, McGannon E. Quality of life after prophylactic colectomy and ileorectal anastamosis in patients with familial adenomatous polyposis. Dis. Colon Rectum 1996; 39: 1404-1408.
18. Van Duijvendijik P, Slors JFM, Tatt CW, Oosterveld P, Vasen HFA. Functional outcome after colectomy and ileorectal anastamosis compared with proctocolectomy and ileal pouch-anal anastamosis with familial adenomatous polyposis. Ann. Surg. 1999; 230: 648-654.
19. Ko CY, Rusin LC, Schoetz DJ Jr etal. Does better functional result equate with better quality of ife? Implications for surgical treatment in familial adenomatous polyposis. Dis. Colon Rectum. 2000; 43: 829-837.
20. Lynch CA, Chruch JM, Lavery IC. QOL following partial colectomy: relevance to HNPCC. Dis. Colon Rectum 2003; 46: A55.
21. You N, Chua H. Segmental vs extened colectomy: measurable differences in morbidity, function, and quality of life. Dis. Colon Rectum. 2008; 51: 1036-1043.
22. Maeda T, Cannom R, Beart RW Jr, Etzionin D. Decision model of segmental compared with total abdominal colectomy for colon cancer in hereditary nonpolyposis colorectal cancer. J Clin. Oncol. 2010; 7: 1175-1180.
23. Nielson M, Morreau H, Vasen HF, Hes HF. MUTYH-associated polyposis (MAP). Crit. Rev. Oncol. Hematol. 2011; 79: 1-16.
24. Sampson JR, Jones N. MUTYH associated polyposis. Best Pract. Res. Clin. Gastroenterol. 2009; 23: 209-218.
25. Balaguer F, Castellvi-Bel S, Castells A etal. Identification of MYH mutation carriers in colorectal cancer: a multicenter, case-control, population-based study. Clin. Gastroenterol. Hepatol. 2007; 5: 379-387.
26. Al Tassan N, Chmiel NH, Maynard J etal. Inherited variants of MYH associated with somatic G:C → T:A mutations in colorectal tumors. Nat. Genet. 2002; 30: 227-232.
27. Desch CE, Benson AB, Somerfield MR etal. ASCO practice guideline recommendations for Colorectal Cancer surveillance: Guideline Summary. J. Clin. Oncol. 2005; 23: 8512-8519.
28. Australian Cancer Network Colorectal Cancer guidelines revision committee. Guidelines for the Prevention, Early Detection and Management of Colorectal Cancer. Sydney, NSW: The Cancer Council Australia and Australian Cancer Network, 2005; 68-80.
29. Vasen HF, Abdahman M, Brohet R etal. One to 2 year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome. Gastroenterology 2010; 138: 2300-2306.
30. Vasen HF, Mecklin JP, Khan PM etal. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer (IGC-HNPCC). Dis. Colon Rectum. 1991; 34: 424-425.
31. Mecklin JP, Aarnio M, Laara E etal. Development of colorectal tumors in colonoscopic surveillance in Lynch syndrome. Gastroenterology 2007; 133: 1093-1098.
32. Vasen HF, Stemorken A, Menko FH etal. MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families. J. Clin. Oncol. 2001; 19: 4074-4080.
33. Schmeler KM, Lynch HT, Chen LM etal. Prophylactic surgery to reduce the risk of gynaecological cancers in the Lynch syndrome. N. Engl. J. Med. 2006; 354: 261-269.
34. Warrier SK, Trainer AH, Lynch AC etal. Preoperative diagnosis of Lynch syndrome with DNA mismatch repair immunohistochemistry on a diagnostic biopsy. Dis. Colon Rectum 2011; 54: 1480-1487.